Back to catalogue
№ 416 39 filings · 2021-09-01 → 2026-09-08

TRIFAST PLC

TRI
Industrial Goods and Services Share price 86.00p Market cap £116m Overall fit 380 /1000

A partial fit for the strategy: indirect AI-receiver exposure via Smart Infrastructure/data centres exists but is only ~17% of revenue, operating leverage is moderate not high, and while valuation is fair-to-slightly-cheap the business quality (declining revenue, restatements, execution volatility) and modest ROCE keep this out of the buy zone.

Fair value range 85p–115p Mid case · £135m
Absolute upside +16.2% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Clean audited financials with clear underlying disclosure
  • Multiple valuation methods converge on similar range
  • Externally validated forward consensus from two joint brokers
Limits the call
  • Fair value depends on unproven >10% medium-term EBIT margin target
  • Recent SaaS restatement and recurring 'one-off' items reduce earnings-quality confidence
Methodology

Blended forward P/E and EV/EBIT on medium-term margin case

In one line · bull case

Management-controlled margin expansion from 7.9% to >10% underlying EBIT on a strong balance sheet, at a fair-to-cheap valuation with genuine (if secondary) AI/data-centre exposure via Smart Infrastructure.

In one line · biggest risk

The turnaround has repeatedly under-delivered, sector is cyclical with heavy automotive weighting, and the AI angle is too small to drive the equity story on its own.

Drivers
AI beneficiary 32 /100
Indirect exposure via Smart Infrastructure fasteners into data centre build-outs (~17% of revenue, targeting 30% by FY30), but no demonstrable AI-driven revenue line at group level.
Operating leverage 45 /100
Distribution-heavy cost base with ~70% variable; some fixed manufacturing absorption but not the 'multiples of profit' dynamic sought — FY26 showed 9% EBIT growth on 7% revenue decline via mix and cost-out.
Earnings vs expectations 45 /100
Two significant profit warnings in FY23/FY24 followed by two years of small in-line/beat deliveries; net pattern is mildly below in-line.
Growth momentum 35 /100
Revenue declined three years running to £208m in FY26; commercial pipeline described as strongest since strategy inception but return to growth not yet in reported numbers.
Moat 30 /100
Modest switching costs with global OEMs and technical service reputation, but fundamentally a specialist distribution business without structural barriers.
Earnings quality 50 /100
Wide gap between underlying (6.46p EPS) and statutory ((0.73)p) EPS, prior-year SaaS restatement of £5.4m, and recurring 'separately disclosed items' — cash conversion of 94% is the mitigant.
Management quality 42 /100
Three CEOs in three years, CFO turnover, and multiple restructurings; new team under Percival is executing but track record is short.
Cyclicality 65 /100
Auto, industrial and construction exposure make demand moderately-to-highly cyclical; FY26 already showed automotive-driven softness.
Leverage 28 /100
Adjusted net debt of £16m at 0.75x underlying EBITDA with £73m undrawn facilities — comfortable, not fortress.
Value-trap signals · 5
  • Revenue declined three consecutive years (£244m → £208m)
  • Prior-year accounting restatement of £5.4m for previously-capitalised SaaS implementation costs
  • Repeated 'one-off' separately-disclosed items every year (£12.3m in FY26, £5.4m in FY25, £7.3m in FY24)
  • Multiple CEO/CFO changes and mid-turnaround uncertainty
  • History of significant profit warnings (Feb 2023, Jan 2024)

Trifast PLC (TRI) — Investment Research Note

Executive summary

Trifast is a UK-listed international distributor and manufacturer of engineered fastenings and Category 'C' components, serving c.65 countries across automotive, smart infrastructure and medical equipment end-markets. The period covered shows a business in the middle of a "Recover, Rebuild, Resilience" turnaround: revenue has slid from £244m (FY23) to £208m (FY26) as management deliberately exited low-margin customers, while underlying EBIT margin has been rebuilt from 4.9% to 7.9% with a clear line-of-sight to a >10% medium-term target. The single most important point today is that at 84p the shares trade on ~13x FY26 underlying EPS and ~7.8x EV/underlying EBIT — a fair-to-cheap multiple for a business whose primary catalyst (margin expansion) is management-controlled rather than market-driven.

Fair value estimate

  • Fair value range: 85p – 115p per share (implied market cap £115m – £155m)
  • Methodology: Blend of (i) forward P/E on FY27 underlying EPS and (ii) EV/EBIT on medium-term margin target.
  • Key assumptions:
    • FY27 consensus revenue £214m, adjusted EBIT £18.6m 2026-09-08 AGM update, implied FY27 underlying EPS ~7.5p → 11–13x P/E gives 82–98p.
    • Medium-term case: if management delivers 10% EBIT on £215m revenue = £21.5m EBIT → ~£13m net income → ~9.6p EPS → at 11–12x = 105–115p.
    • EV/underlying EBIT of 8–10x on FY27 EBIT of £18.6m plus £16m net debt supports £133–170m EV → £117–154m equity (~87p–114p).
  • Mid-point ~100p vs. current 84p → +19% absolute upside, or +36% at the top of the range.
  • The current £113m market cap already discounts ongoing margin recovery but does not fully price the >10% medium-term target.

Sector context

  • Sector classification confirmed: Industrial Goods and Services (ICB Industrials). This is a specialist industrial distributor with in-house manufacturing (cold-forged fasteners) — a hybrid distribution/light manufacturing model.
  • Quality/growth/leverage profile is below typical peers in the diversified industrial distribution space. ROCE of 8.5% 2026-07-02 final results is modest; growth has been negative for three consecutive years; balance sheet is fine but not fortress.
  • Listed peers: Diploma PLC (much higher quality/multiple), DiscoverIE Group (specialist components, similar hybrid model), Bufab AB (Swedish direct fastener peer — closest comparable), and to a lesser degree Bunzl (larger diversified distribution).

Investment thesis (3 bullets)

  1. Self-help margin story with visible progress and low execution risk on the incremental step. Underlying EBIT margin has moved from 4.9% (FY23) → 6.7% (FY25) → 7.9% (FY26) and management has "clear line of sight" to >10% 2026-07-02 final results. Reaching 10% on flat revenue would add ~£4-5m to EBIT, or roughly 30% to earnings, without needing a demand recovery.
  2. Portfolio-mix shift to Smart Infrastructure (data centres, power distribution, HVAC) provides indirect AI-buildout exposure. Smart Infrastructure is 17% of the portfolio, targeting 30% by FY30, with 15% growth in North America and specific mentions of "data centre roll outs driven by global investment in Artificial Intelligence" 2025-11-18 half-year report. This is a genuine second-derivative AI-receiver angle, not a press-release mention.
  3. Robust balance sheet (0.75x leverage, £32m cash, £73m undrawn facilities) supports bolt-on acquisitions and cash returns while trading at a modest valuation. ROCE improving to 8.5%, cash conversion of 94%, and 6% dividend growth (1.90p) 2026-07-02 final results provide downside protection.

Key risks (3 bullets)

  1. Automotive cyclicality and OEM concentration risk. North American auto business specifically called out as impacted 2026-09-08 AGM trading update; UK automotive suffered from a customer cyber-attack in FY26 2026-07-02 final results. Auto exposure amplifies any recessionary or EV-transition demand shock.
  2. Track record of guidance misses and restructuring charges. Multiple profit warnings (Jan 2024, Feb 2023), a prior-year accounting restatement of £5.4m for capitalised SaaS costs 2026-07-02 final results, Malaysia manufacturing write-off, facilitation-payment fraud, and CEO/CFO turnover — all suggest the operational base is still fragile.
  3. Refinancing risk on the £70m RCF (matures June 2028) and £50m UKEF facility (matures 2028) 2026-07-02 final results in a higher-rate environment. Interest cost of £4.3m already meaningfully impacts PBT (34% of underlying EBIT).

Operating leverage

Trifast's operating leverage is moderate, not high. FY26 demonstrates the mechanism working in reverse: revenue fell 7.3% but underlying EBIT rose 9.4%, driven by mix (30.0% GP vs 28.3%), pricing discipline, and structural cost-out including exit of Malaysia manufacturing and consolidation to a UK National Distribution Centre. Total payroll costs fell to £45.8m from £49.0m and headcount to 1,020 from 1,176 2026-07-02 final results. Central costs of ~£4.7m and manufacturing footprint provide fixed-cost absorption benefits on volume recovery. However, this is fundamentally a distribution business — cost of sales was £146m on £208m revenue, so ~70% of the cost base moves with volume. Rule of thumb: a 10-20% revenue beat at current gross margins would flow ~30% to gross profit and, given semi-fixed overheads of ~£47m, could plausibly add ~50-70% to operating profit — meaningful but not the "multiples of profit" the strategy user is seeking. The path to >10% EBIT margin is more about mix and execution than volume leverage.

Value-trap signals

  • Revenue has declined for three consecutive years (FY23: £244m → FY24: £234m → FY25: £223m → FY26: £208m).
  • Multi-year "turnaround" strategy (Recover, Rebuild, Resilience) — the market may be sceptical because prior transformation programmes (Project Atlas ERP) went materially over budget/timeline.
  • Prior-year restatement of £5.4m for previously-capitalised SaaS costs indicates historical accounting judgement issues.
  • Repeated separately-disclosed items every year (£12.3m in FY26, £5.4m in FY25, £7.3m in FY24) suggest "one-off" charges are recurring.
  • CEO turnover: three CEOs in three years (Belton → Mac Meekin interim → Percival).
  • Statutory EPS was (0.73)p in FY26 vs. underlying 6.46p — a wide reported-vs-underlying gap.

Earnings vs. expectations

Across the period the pattern is: two significant profit warnings (Feb 2023, Jan 2024) followed by two years of in-line/slight beats. The Feb 2023 warning cut adjusted PBT guidance from consensus of £14.3m to £9m; the Jan 2024 warning cut FY24 EBIT to ~5% margin vs. previous £15.5m consensus. Since then, FY25 delivered EBIT of £14.9m vs. consensus £14.6m (small beat), FY26 delivered £16.5m vs. consensus £16.0m 2026-04-29 trading statement (small beat), and HY26 and Q3 FY26 trading updates confirmed in-line performance. Under new leadership the delivery has become more predictable, but the historical volatility means investors are unlikely to pay a premium multiple for beats until a longer track record is established.

Conviction

Rating: 3 (moderate).

  • Supporting: (i) audited financials with clean auditor opinion, (ii) multiple valuation methodologies converge on 85-115p, (iii) FY27 consensus is externally validated by two joint brokers (Berenberg, Singer).
  • Limiting: (i) the fair value depends on whether the >10% EBIT margin target is achieved — a strategic aspiration not yet demonstrated, (ii) recent restatement and multiple separately-disclosed items reduce reported-earnings quality, (iii) small-cap with low analyst coverage means consensus is thin.
Filings consulted · 42

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-08Result OF Agm2026-09-08_9761365_result-of-agm.md0.30
  2. 2026-09-08Agm Trading Update2026-09-08_9759771_agm-trading-update.md0.85
  3. 2026-08-27Confirmation OF Final Dividend Timetable2026-08-27_9744061_confirmation-of-final-dividend-timetable.md0.30
  4. 2026-07-02Final Results2026-07-02_9648414_final-results.md1.00
  5. 2026-04-29Trading Statement2026-04-29_9542855_trading-statement.md0.85
  6. 2026-02-12Trading Statement2026-02-12_9426737_trading-statement.md0.72
  7. 2025-11-18Half Year Financial Report2025-11-18_9239758_half-year-financial-report.md0.77
  8. 2025-10-21Trading Statement2025-10-21_9183107_trading-statement.md0.72
  9. 2025-09-11Trading Statement2025-09-11_9100537_trading-statement.md0.55
  10. 2025-09-11Result OF Agm2025-09-11_9102332_result-of-agm.md0.20
  11. 2025-07-22Notice OF Agm2025-07-22_8991122_notice-of-agm.md0.20
  12. 2025-07-10Final Results2025-07-10_8972120_final-results.md0.65
  13. 2025-04-30Trading Update Amp Notice OF Fy25 Annual Results2025-04-30_8853000_trading-update-amp-notice-of-fy25-annual-results.md0.65
  14. 2025-02-13Trading Update2025-02-13_8734490_trading-update.md0.55
  15. 2024-11-19Half Yearly Financial Report2024-11-19_8557978_half-yearly-financial-report.md0.58
  16. 2024-10-22Trading Update And Notice OF Half Year Results2024-10-22_8499953_trading-update-and-notice-of-half-year-results.md0.58
  17. 2024-09-10Result OF Agm2024-09-10_8409557_result-of-agm.md0.14
  18. 2024-09-10Agm Statement2024-09-10_8407933_agm-statement.md0.18
  19. 2024-07-31Availability OF Annual Report Amp Notice OF Meeting2024-07-31_8341860_availability-of-annual-report-amp-notice-of-meeting.md0.43
  20. 2024-07-29Annual Results 31 March 2024 Annual Report2024-07-29_8334619_annual-results-31-march-2024-annual-report.md0.45
  21. 2024-07-23Fy24 Annual Results Date Confirmation2024-07-23_8324575_fy24-annual-results-date-confirmation.md0.45
  22. 2024-06-11Annual Results Presentations2024-06-11_8253292_annual-results-presentations.md0.45
  23. 2024-04-25Trading Update Amp Notice OF Annual Results2024-04-25_8155650_trading-update-amp-notice-of-annual-results.md0.45
  24. 2024-01-22Trading Update2024-01-22_7998841_trading-update.md0.38
  25. 2023-11-21Half Year Report Six Months TO 30 September 20232023-11-21_7893115_half-year-report-six-months-to-30-september-2023.md0.41
  26. 2023-10-24Half Year Trading Update And Notice OF Results2023-10-24_7834551_half-year-trading-update-and-notice-of-results.md0.41
  27. 2023-09-15Result OF Agm2023-09-15_7758856_result-of-agm.md0.07
  28. 2023-07-11Annual Results 31 March 2023 Annual Report2023-07-11_7624334_annual-results-31-march-2023-annual-report.md0.25
  29. 2023-06-09Notice OF Annual Results2023-06-09_7567186_notice-of-annual-results.md0.25
  30. 2023-04-26Trading Update2023-04-26_4409_trading-update.md0.21
  31. 2023-02-20Trading Update And Directorate Change2023-02-20_7485824_trading-update-and-directorate-change.md0.21
  32. 2022-11-22Half Yearly Report Six Months Ended 30 9 222022-11-22_7454080_half-yearly-report-six-months-ended-30-9-22.md0.23
  33. 2022-10-20Trading Update Amp Notice OF Half Year Results2022-10-20_7385162_trading-update-amp-notice-of-half-year-results.md0.23
  34. 2022-09-07Result OF Agm2022-09-07_7269129_result-of-agm.md0.07
  35. 2022-08-03Availability OF Annual Report Amp Notice OF Meeting2022-08-03_7008254_availability-of-annual-report-amp-notice-of-meeting.md0.24
  36. 2022-07-26Publication OF The 2022 Annual Results2022-07-26_7136119_publication-of-the-2022-annual-results.md0.25
  37. 2022-07-04Notice OF 2022 Annual Results2022-07-04_6866799_notice-of-2022-annual-results.md0.25
  38. 2022-05-05Trading Update Amp Notice OF Annual Results2022-05-05_7192743_trading-update-amp-notice-of-annual-results.md0.25
  39. 2022-02-24Q3 Trading Update2022-02-24_6926222_q3-trading-update.md0.21
  40. 2021-11-23Half Yearly Financial Report TO 30 September 20212021-11-23_6837520_half-yearly-financial-report-to-30-september-2021.md0.23
  41. 2021-10-21Trading Update And Notice OF Half Year Results2021-10-21_6522471_trading-update-and-notice-of-half-year-results.md0.23
  42. 2021-09-01TR Acquisition Enhancing North American Offering2021-09-01_6696544_tr-acquisition-enhancing-north-american-offering.md0.07

This research note was authored by a large language model after reading 39 regulatory filings published between 2021-09-01 and 2026-09-08. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.